Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Almado, Inc. (4932.T)
Tokyo, JP
Almado, Inc. is a Japanese firm dedicated to the creation, formulation, and distribution of various beauty and wellness products. The company's diverse range includes skincare basics, decorative makeup, nutritional supplements, and quasi-pharmaceutical items, all marketed under prominent brands such as TO-II, Ode, CELLULA, Type III, AMF, and Almado La Dina, alongside others. Additionally, Almado facilitates sales through its dedicated online retail channels. Established in 2000, the company's main office is situated in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.05% | +0.28% | -4.39% | -23.35% | -33.12% | -36.82% | -31.59% | -43.56% | -27.74% | -27.74% | -27.74% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+19.4% ★ Q1'26: -2.9% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-20.4% Q1'26: +16.1% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+8.5% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+6.8% Q1'26: +26.9% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+23.4% ★ Q1'26: +75.0% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.1% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×2.82× Q1'26: 0.92× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
5.37B
est: 5.35B (+0.3%)
|
6.53B
est: 6.50B (+0.4%)
|
7.54B
est: 7.70B (-2.1%)
|
8.48B
est: 9.00B (-5.8%)
|
10.00B
10.00B – 10.00B
+11.1% YoY
|
11.30B
11.30B – 11.30B
+13.0% YoY
|
| EBITDA |
852.31M
est: 705.53M (+20.8%)
|
847.45M
est: 857.19M (-1.1%)
|
976.55M
est: 1.01B (-3.1%)
|
978.24M
est: 1.18B (-16.9%)
|
1.31B
1.31B – 1.31B
+11.1% YoY
|
1.48B
1.48B – 1.48B
+13.0% YoY
|
| EBIT |
835.73M
est: 688.37M (+21.4%)
|
831.73M
est: 836.34M (-0.6%)
|
960.54M
est: 982.68M (-2.3%)
|
946.46M
est: 1.15B (-17.6%)
|
1.28B
1.28B – 1.28B
+11.1% YoY
|
1.44B
1.44B – 1.44B
+13.0% YoY
|
| Net Income |
582.21M
est: 507.95M (+14.6%)
|
585.80M
est: 541.19M (+8.2%)
|
695.46M
est: 752.68M (-7.6%)
|
650.41M
est: 827.50M (-21.4%)
|
965.26M
965.26M – 965.26M
+16.6% YoY
|
1.03B
1.03B – 1.03B
+7.1% YoY
|
| SGA |
2.38B
est: 2.79B (-14.7%)
|
3.41B
est: 3.39B (+0.7%)
|
4.02B
est: 3.93B (+2.4%)
|
4.85B
est: 4.59B (+5.7%)
|
5.10B
5.10B – 5.10B
+11.1% YoY
|
5.76B
5.76B – 5.76B
+13.0% YoY
|
| EPS |
57.81
est: 55.00 (+5.1%)
|
60.29
est: 58.60 (+2.9%)
|
72.98
est: 81.50 (-10.5%)
|
70.43
est: 89.50 (-21.3%)
|
104.40
104.40 – 104.40
+16.6% YoY
|
111.80
111.80 – 111.80
+7.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hiromasa Warabi | MD & Director | — | male |
| Shiro Hoshina | Chairman, Chief Executive Officer & President | — | male |
| Yuichiro Aso | Director of Sales & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4932.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
